MRNS - Marinus stock falls 9% amid Q1 report cost-cutting measures
2024-05-08 16:15:29 ET
More on Marinus Pharmaceuticals
- Marinus Pharmaceuticals, Inc. (MRNS) Q4 2023 Earnings Call Transcript
- Marinus plummets 78% as phase 3 interim analysis of ganaxolone disappoints
- Marinus Pharmaceuticals Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Marinus Pharmaceuticals
- Historical earnings data for Marinus Pharmaceuticals